A new approach to Huntington’s disease?
At the 2014 AAN Annual Meeting, investigators reported the results of a double-blind, placebo-controlled, international multi-center study of selisistat in individuals with Huntington’s disease (HD)
We’d love to hear your feedback on this activity. It helps us to continually improve our products.
At the 2014 AAN Annual Meeting, investigators reported the results of a double-blind, placebo-controlled, international multi-center study of selisistat in individuals with Huntington’s disease (HD)